Learning Objectives:

  • Review the mechanism of action of nirsevimab and the studies that brought it to market.
  • Review the AAP/CDC criteria for administration and the NorthShore aspirations for delivery and work flows.
  • Overview of counseling and anticipatory guidance for families.


Session date: 
09/13/2023 - 8:00am to 9:00am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Matthew Pellerite, MD